Diana Rinkevich is a Cardiology physician affiliated with Oregon Health & Science University. OpenAlex indexes 36 publications with 1,195 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2095 Exchange St Ste 301
Astoria, OR 971033400
Telephone
503-338-4087Provider last certified this registry record 22 Jan 2026.
Clinical trials
- Elucidating the Role of Microvascular Dysfunction in Heart Disease in Women
Sponsor: Oregon Health and Science University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.8%Beta blocker25.2%Metoprolol Succinate82%Metoprolol Tartrate8%Carvedilol7%Nebivolol Hcl2%Part D<11 patientsStatin12.9%Atorvastatin Calcium67%Rosuvastatin Calcium33%Part D≥56 patients+ 10 more classes in this area
Blood & clotting
17.1%Factor Xa inhibitor9.5%Eliquis85%Xarelto15%Part D≥40 patientsVitamin K antagonist6.7%Warfarin Sodium100%Part D≥55 patients+ 1 more class in this area
Metabolism & gastrointestinal
11.1%SGLT2 inhibitor7.7%Jardiance84%Farxiga16%Part D<11 patientsPotassium supplement2.6%Potassium Chloride100%Part D≥14 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Plasma Oxylipins: A Potential Risk Assessment Tool in Atherosclerotic Coronary Artery Disease
Frontiers in Cardiovascular Medicine
2021 - OXYLIPINS PREDICT PRESENCE AND EXTENT OF OBSTRUCTIVE CORONARY ARTERY DISEASE
Journal of the American College of Cardiology
2020 - Coronary Autoregulation Is Abnormal in Syndrome X: Insights Using Myocardial Contrast Echocardiography
Journal of the American Society of Echocardiography
2013 - Abstract 16236: Role of Epoxyeicosatrienoic Acids in Syndrome X in Women
Circulation
2011 - Our thanks to reviewers in 2011
The consultant
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”